155 related articles for article (PubMed ID: 15551121)
1. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
Lai MK; Tsang SW; Alder JT; Keene J; Hope T; Esiri MM; Francis PT; Chen CP
Psychopharmacology (Berl); 2005 May; 179(3):673-7. PubMed ID: 15551121
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
Garcia-Alloza M; Hirst WD; Chen CP; Lasheras B; Francis PT; Ramírez MJ
Neuropsychopharmacology; 2004 Feb; 29(2):410-6. PubMed ID: 14571255
[TBL] [Abstract][Full Text] [Related]
3. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
4. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study.
Marner L; Frokjaer VG; Kalbitzer J; Lehel S; Madsen K; Baaré WF; Knudsen GM; Hasselbalch SG
Neurobiol Aging; 2012 Mar; 33(3):479-87. PubMed ID: 20510480
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
Bowen DM; Procter AW; Mann DM; Snowden JS; Esiri MM; Neary D; Francis PT
Psychopharmacology (Berl); 2008 Mar; 196(4):603-10. PubMed ID: 18026720
[TBL] [Abstract][Full Text] [Related]
6. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
Hasselbalch SG; Madsen K; Svarer C; Pinborg LH; Holm S; Paulson OB; Waldemar G; Knudsen GM
Neurobiol Aging; 2008 Dec; 29(12):1830-8. PubMed ID: 17544547
[TBL] [Abstract][Full Text] [Related]
7. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
[TBL] [Abstract][Full Text] [Related]
9. Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition.
Elliott MS; Ballard CG; Kalaria RN; Perry R; Hortobágyi T; Francis PT
Brain; 2009 Jul; 132(Pt 7):1858-65. PubMed ID: 19433439
[TBL] [Abstract][Full Text] [Related]
10. A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.
Tsang SW; Keene J; Hope T; Spence I; Francis PT; Wong PT; Chen CP; Lai MK
J Neurol Sci; 2010 Jan; 288(1-2):151-5. PubMed ID: 19818455
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.
Holmes C; McCulley M; Nicoll JA; Alder JT; Chen CP; Francis PT
Neurosci Lett; 2007 Jun; 420(1):58-60. PubMed ID: 17481814
[TBL] [Abstract][Full Text] [Related]
12. The reduction of baseline serotonin 2A receptors in mild cognitive impairment is stable at two-year follow-up.
Marner L; Knudsen GM; Madsen K; Holm S; Baaré W; Hasselbalch SG
J Alzheimers Dis; 2011; 23(3):453-9. PubMed ID: 21098981
[TBL] [Abstract][Full Text] [Related]
13. Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
Huot P; Johnston TH; Darr T; Hazrati LN; Visanji NP; Pires D; Brotchie JM; Fox SH
Mov Disord; 2010 Jul; 25(10):1399-408. PubMed ID: 20629135
[TBL] [Abstract][Full Text] [Related]
14. [3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study.
Lai MK; Tsang SW; Francis PT; Esiri MM; Hope T; Lai OF; Spence I; Chen CP
J Neural Transm (Vienna); 2003 Jul; 110(7):779-88. PubMed ID: 12811638
[TBL] [Abstract][Full Text] [Related]
15. Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem study.
Kang K; Huang XF; Wang Q; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):867-71. PubMed ID: 19389456
[TBL] [Abstract][Full Text] [Related]
16. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
[TBL] [Abstract][Full Text] [Related]
17. Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings.
Versijpt J; Van Laere KJ; Dumont F; Decoo D; Vandecapelle M; Santens P; Goethals I; Audenaert K; Slegers G; Dierckx RA; Korf J
Neurobiol Aging; 2003; 24(4):553-61. PubMed ID: 12714112
[TBL] [Abstract][Full Text] [Related]
18. Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
Lai MK; Tsang SW; Francis PT; Keene J; Hope T; Esiri MM; Spence I; Chen CP
Neuroreport; 2002 Jul; 13(9):1175-8. PubMed ID: 12151764
[TBL] [Abstract][Full Text] [Related]
19. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.
Jagust WJ; Eberling JL; Richardson BC; Reed BR; Baker MG; Nordahl TE; Budinger TF
Brain Res; 1993 Dec; 629(2):189-98. PubMed ID: 8111623
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
